glp-1 agonist home delivery clinics Injections Lafayette LA GLP-1 Pipeline Update: May 2026

2022A pilot clinical study to Evaluate liraglutide-mediated anti-platelet activity in patients with type-2 Diabetes (ELAID study)

21,22 They cloned and sequenced the preproglucagon gene, discovering GLP-1 and GLP-2 hormones

15,351,352 Moreover, lixisenatide has been shown to inhibit matrix metalloproteinase (MMP) activity and effectively block various cell signaling pathways, including the JNK, activator protein-1, and NF-B pathways

M., Ma, X

Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate

2007;13(2 Suppl):S55-S58